TrialBMC medicine2026

R-MINE-containing regimen in relapsed and refractory diffuse large B-cell lymphoma: a single-arm, multicenter phase II study.

Jin-Hua Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.